Literature DB >> 21046167

Successful treatment and clearing of circulating CD19-positive cells by rituximab in a child with idiopathic membranous nephropathy.

Bizhen Zhu, Jianping Huang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21046167     DOI： 10.1007/s00467-010-1671-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  4 in total

1.  CD20-positive infiltrates in human membranous glomerulonephritis.

Authors:  Clemens D Cohen; Novella Calvaresi; Silvia Armelloni; Holger Schmid; Anna Henger; Undine Ott; Maria P Rastaldi; Matthias Kretzler
Journal:  J Nephrol       Date:  2005 May-Jun       Impact factor: 3.902

2.  Rituximab for idiopathic membranous nephropathy.

Authors:  Giuseppe Remuzzi; Carlos Chiurchiu; Mauro Abbate; Verusca Brusegan; Mario Bontempelli; Piero Ruggenenti
Journal:  Lancet       Date:  2002-09-21       Impact factor: 79.321

3.  Rituximab treatment of idiopathic membranous nephropathy.

Authors:  F C Fervenza; F G Cosio; S B Erickson; U Specks; A M Herzenberg; J J Dillon; N Leung; I M Cohen; D N Wochos; E Bergstralh; M Hladunewich; D C Cattran
Journal:  Kidney Int       Date:  2007-10-17       Impact factor: 10.612

4.  Idiopathic membranous nephropathy in children.

Authors:  Beom Hee Lee; Hee Yeon Cho; Hee Gyung Kang; Il Soo Ha; Hae Il Cheong; Kyung Chul Moon; In Seok Lim; Yong Choi
Journal:  Pediatr Nephrol       Date:  2006-09-02       Impact factor: 3.651
  4 in total
  1 in total

1.  Idiopathic membranous nephropathy in children treated with rituximab: report of two cases.

Authors:  Rossana Malatesta-Muncher; Karen W Eldin; Laurence H Beck; Mini Michael
Journal:  Pediatr Nephrol       Date:  2018-03-15       Impact factor: 3.714
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.